Effects of NF-κB Inhibitor Pyrrolidine Dithiocarbamate (PDTC) on Mrna Expression of High Mobility Group Box-1 Protein in Organs of Rats with Endotoxic Shock

胥彩林,姚咏明,于燕,王松柏
DOI: https://doi.org/10.3969/j.issn.1672-8521.2003.03.005
2004-01-01
Abstract:Objective To investigate the effect of nuclear factor-kappa B (NF-κB) signal transcription pathway inhibitor-pyrrolidine dithiocarbamate (PDTC) on mRNA expression of high mobility group box-1 protein (HMGB1) in organs of rats with endotoxic shock and its potential mechanism. Methods Forty-seven male Wistar rats were randomly divided into normal control group (n=8), endotoxic shock group (n=24), and PDTC treatment group (n=15). At serial time points, the animals in each group were sacrificed, and tissue samples from the liver, lungs and kidneys were harvested to determine HMGB1 mRNA expression and pulmonary MPO activity. Also, blood samples were collected to determine the major organ functional indices. Results Compared to normal controls, HMGB1 mRNA levels were significantly increased in samples from the liver, lungs and kidneys at 2-6h after endotoxin challenge (P0.05), and the levels remained elevated up to 12h. Meanwhile, serum ALT, AST, BUN, Cr levels as well as pulmonary MPO activity were significantly elevated in the animals following endotoxic shock (P0.05 or 0.01). Treatment with PDTC could markedly down-regulate HMGB1 mRNA expressions in various organs at 12h compared with endotoxic shock group (P0.05 or 0.01). In addition, PDTC treatment could significantly reduce serum ALT, AST, BUN, as well as Cr levels at 6h (P0.05) and MPO activity at 2-12h. Conclusions These data suggest that NF-κB signal transcription pathway may be involved in regulating mRNA expression of HMGB1 in rats after endotoxic shock. Early treatment with NF-κB inhibitors can down-regulate HMGB1 gene expression in vital organs and attenuate endotoxin-induced multiple organ dysfunction.
What problem does this paper attempt to address?